DaazPrime

DaazPrime

Starknet introduces wallet privacy feature for DeFi activity

<!–> –> Written by Ezra Reguerrastaff writerEdited by Felix Ngstaff editor Written by Ezra Reguerrastaff writer Edited by Felix Ngstaff editor Starknet introduces wallet privacy feature for DeFi activity Latest NewsPublishedOct 14, 2026<!–> Starknet’s Shadow Accounts allow users to obscure…

OpenAI Used Its Own AI to Investigate a Hidden Office Recorder

A hidden recorder in a conference room can expose information that never reaches a company’s servers. At OpenAI, an employee allegedly installed one in an executive conference room where confidential research and business plans were discussed. OpenAI says investigators later…

Bitwise’s Hougan says Q3 charts point to ‘crypto spring’

Bitwise Asset Management Chief Investment Officer Matt Hougan believes that recent third-quarter data and market charts strongly indicate the arrival of a new crypto spring. Despite lingering macroeconomic uncertainties and sluggish price action earlier in the year, Hougan points to surging institutional interest, expanding network activity, and favorable underlying metrics as catalysts for a renewed bull market. This optimistic outlook suggests that the digital asset sector is successfully shaking off the prolonged crypto winter, paving the way for sustainable growth and heightened investor confidence in the months ahead.

Lyell Immunopharma CMO sells $3,641 in shares for tax withholding

Lyell Immunopharma’s Chief Medical Officer recently executed a routine stock transaction, selling 700 shares of common stock valued at approximately $3,641. The open-market sale, executed at a weighted average price of $5.20 per share, was conducted under a predetermined Rule 10b5-1 trading plan. According to regulatory filings, the transaction was not a discretionary move by the executive but was specifically mandated to cover tax withholding obligations tied to the vesting of restricted stock units. Following this necessary financial adjustment, the executive retains direct ownership of 465,583 shares in the clinical-stage biopharmaceutical company.

PodcastOne director D. Jonathan Merriman buys $9,776 in shares

D. Jonathan Merriman, a director at PodcastOne, recently demonstrated his confidence in the company by purchasing $9,776 worth of shares on the open market. This insider transaction highlights ongoing leadership support for the digital audio podcast network as it navigates the competitive media landscape. Such insider buying is frequently interpreted by investors as a positive signal regarding the company's financial health and future growth prospects. While the financial investment is relatively modest, executive-level acquisitions often capture the attention of market watchers tracking insider sentiment.